Evidence map›Paper›PMID 41345543›Full record

ArticleBMC genomic data2025

Phylogenetic and motif-based genomic analysis of Mokola virus: implications for regional divergence and data gaps.

Elijah Kolawole Oladipo, James Akinwumi Ogunniran, Oluwaseyi Samuel Akinpelu, Kehinde Abel Ajadi, Blessing Ogbene Andy, Hezekiah Oluwajoba Awobiyi, Bamidele Abiodun Iwalokun, Olatunji Matthew Kolawole, Helen Onyeaka, Julius Kola Oloke

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC genomic data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elijah Kolawole OladipoDivision of Vaccine and Pharmacotherapies Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria. koladipo2k3@yahoo.co.uk.
James Akinwumi OgunniranDivision of Vaccine and Pharmacotherapies Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.
Oluwaseyi Samuel AkinpeluDivision of Vaccine and Pharmacotherapies Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.
Kehinde Abel AjadiDepartment of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.
Blessing Ogbene AndyDepartment of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.
Hezekiah Oluwajoba AwobiyiDepartment of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.
Bamidele Abiodun IwalokunMolecular Biology and Biotechnology Department, Nigeria Institute of Medical Research, Lagos, Nigeria.
Olatunji Matthew KolawoleDepartment of Microbiology, University of Ilorin, Ilorin, 234031, Nigeria.
Helen OnyeakaDepartment of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, B12 2TT, UK.
Julius Kola OlokeDepartment Microbiology and Biotechnology, LAUTECH, Ogbomoso, Oyo State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

clinical trial numberNot applicable.

Indexed as

Genome, ViralGenomicsPhylogenyAnimalsEvolution, MolecularHumansComparative genomicsLyssavirusMokola virusPhylogenetic analysisViral evolutionZoonotic transmission

Identifiers

PMID41345543
PMCPMC12794389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.